NCT00184678

Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency

Effect of Two Years of Treatment With Norditropin® SimpleXx® on Bone Mineral Density in Young Adults With Childhood-Onset Growth Hormone Deficiency

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 161 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 18 Years – 25 Years
• Healthy volunteers: Not accepted

Summary

This trial is conducted in Europe. Growth Hormone in young adults with growth hormone deficiency in childhood. This trial compares a treated group of patients with an untreated group of patients.

Conditions

• Growth Hormone Disorder
• Adult Growth Hormone Deficiency

Interventions

Type	Name	Description
DRUG	somatropin

Timeline

• Start date: 2002-02-01
• Primary completion: 2006-07-01
• Completion: 2006-07-01
• First posted: 2005-09-16
• Last updated: 2017-01-13

Locations

30 sites across 12 countries: Australia, Austria, Belgium, France, Germany, Hungary, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom